I'm not convinced Lympro is a dud and think another company might be able to get somewhere with it. The CLIA lab is the key to that deal and could expedite the potential for revenue. We'll see how it goes. Good luck to you Tanis.
(1)
(1)
Amarantus Bioscience Holdings (AMBS) Stock Research Links
